<!DOCTYPE html>
<!--[if lt IE 7]><html class="no-js ie6 oldie ieall" lang="en" xmlns="http://www.w3.org/1999/xhtml"><![endif]-->
<!--[if IE 7]><html class="no-js ie7 oldie ieall" lang="en" xmlns="http://www.w3.org/1999/xhtml"><![endif]-->
<!--[if IE 8]><html class="no-js ie8 oldie ieall" lang="en" xmlns="http://www.w3.org/1999/xhtml"><![endif]-->
<!--[if IE 9]><html class="no-js ie9 ieall" lang="en" xmlns="http://www.w3.org/1999/xhtml"><!<![endif]-->
<!--[if (gt IE 9)|(gt IEMobile 7)|!(IEMobile)|!(IE)]><!--><html class="no-js" lang="en" xmlns="http://www.w3.org/1999/xhtml"><!--<![endif]-->
<head>
       
<script type="text/javascript">window.NREUM||(NREUM={});NREUM.info={"beacon":"beacon-1.newrelic.com","errorBeacon":"jserror.newrelic.com","licenseKey":"c2a5bf7b54","applicationID":"2502042","transactionName":"IlheTBRdCQ8DQxxWWg9DVVYSHRUWBF1aVmoSX19P","queueTime":0,"applicationTime":281,"ttGuid":"","agentToken":null,"agent":"js-agent.newrelic.com/nr-298.min.js","extra":""}</script>
<script type="text/javascript">window.NREUM||(NREUM={}),__nr_require=function a(b,c,d){function e(f){if(!c[f]){var g=c[f]={exports:{}};b[f][0].call(g.exports,function(a){var c=b[f][1][a];return e(c?c:a)},g,g.exports,a,b,c,d)}return c[f].exports}for(var f=0;f<d.length;f++)e(d[f]);return e}({"4O2Y62":[function(a,b){function c(a,b){var c=d[a];return c?c.apply(this,b):(e[a]||(e[a]=[]),void e[a].push(b))}var d={},e={};b.exports=c,c.queues=e,c.handlers=d},{}],handle:[function(a,b){b.exports=a("4O2Y62")},{}],YLUGVp:[function(a,b){function c(){var a=m.info=NREUM.info,b=m.proto="https"===l.split(":")[0]||a.sslForHttp?"https://":"http://";if(a&&a.agent&&a.licenseKey&&a.applicationID){f("mark",["onload",e()]);var c=h.createElement("script");c.src=b+a.agent,h.body.appendChild(c)}}function d(){"complete"===h.readyState&&f("mark",["domContent",e()])}function e(){return(new Date).getTime()}var f=a("handle"),g=window,h=g.document,i="readystatechange",j="addEventListener",k="attachEvent",l=(""+location).split("?")[0],m=b.exports={offset:e(),origin:l};h[j]?(h[j](i,d,!1),g[j]("load",c,!1)):(h[k]("on"+i,d),g[k]("onload",c)),f("mark",["firstbyte",e()])},{handle:"4O2Y62"}],loader:[function(a,b){b.exports=a("YLUGVp")},{}]},{},["YLUGVp"]);</script>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta name="keywords" content="newsletter, dynport, partners, vaccine, biopharmaceutical, business development, EVMS" />
  <meta name="description" content="The latest biopharmaceutical product development and government contracting news and events from DynPort, for our partners." />
  <meta name="geo.region" content="US" />
  <meta content="article" property="og:type" />
  <meta content="Hot topics, biotech funding, and abstract deadlines" property="og:title" />
  <meta content="The latest biopharmaceutical product development and government contracting news and events from DynPort, for our partners." property="og:description" />
  <meta content="http://www.csc.com/dvc/blog/41185/78382-hot_topics_biotech_funding_and_abstract_deadlines" property="og:url" />
  <meta content="en-US" property="og:locale" />
  <meta content="Computer Sciences Corporation" property="og:site_name" />
  <link rel="canonical" href="78382-hot_topics_biotech_funding_and_abstract_deadlines.html" />
  <title>Hot topics, biotech funding, and abstract deadlines | CSC</title>

  <script type="text/javascript">
    var responsive=true ;
  </script>


    <script type="text/javascript">
      var responsive = true;
    </script>
    <!--[if lte IE 8]>
      <script type="text/javascript">responsive = false;</script>
    <![endif]-->
    <![if gt IE 8]>
    <meta name="viewport" content="initial-scale=1,maximum-scale=1,width=device-width" />
     <link href="../../../stylesheets/user/global-bundle-78733079cb421825fca5a903046c770c.css" media="all" rel="stylesheet" type="text/css" />
    <![endif]>
    <!--[if lte IE 8]>
       <link href="../../../stylesheets/user/global_non_responsive-bundle-9ef563e134b588f9a45b5060ad4b78aa.css" media="all" rel="stylesheet" type="text/css" />
    <![endif]-->
    

       <link href="../../../assets/public/comments-7c37505c1a6e388ce4e34a78fbb12494.css" media="screen" rel="stylesheet" type="text/css" />
    <link href="../../../stylesheets/user/blogdetail-492cb34d506631f042187b0a924bc649.css" media="all" rel="stylesheet" type="text/css" />

    <![if gt IE 8]>
    <script src="../../../javascripts/user/global-bundle-8889b0584423b7383dba5816ff101fd5.js" type="text/javascript"></script>
    <![endif]>
    <!--[if lte IE 8]>
      <script src="../../../javascripts/user/global_non_responsive-bundle-8385e9848036be955101f89324885409.js" type="text/javascript"></script>
    <![endif]-->
    


  <!--[if lt IE 9]>
  <script src="../../../javascripts/user/printshiv-min-68e071550e9b2f652850bf54693181a1.js" type="text/javascript"></script>
  <!<![endif]-->

<script>
$csc().gigya.init("2_znZ6oKy7notCLVoNArGFVv8LPRNmj8f3YN1TN-Hxt0Q1xFL2-tD8kc84bP_jARhA");
</script>


  <script type="text/javascript">
    include_default_css = true;
    //translations
    ls_header = "CSC Live Search: Quick Results";
    ls_see = "Don't see what you're looking for?";
          ls_search = "Search all over";
    ls_results = "for more results";
    mn_navigation = "Navigation";
    mn_countrySelect = "Worldwide";
    mn_search = "Search";
  </script>

  
</head>
<body itemscope itemtype="http://schema.org/WebPage">
    <script src="../../../javascripts/user/mbox_js-min-c4e062b0e669784dee7d810bbaa1f418.js" type="text/javascript"></script>
  <script type="text/javascript">
          setupCampaignTracking();
          var s_code = null;
          var _gaq = null;
          visitorOrg = null;
          var db_err = null;
        </script>
    <script src="../../../javascripts/user/s_code-min-38fd02ddea4b57c76bed86493f62daa0.js" type="text/javascript"></script>
  
  <script type="text/javascript">
    var contentID = '';
    var zoneID = '';
    var contentTypeID = '';
    s.charSet="UTF-8";
    s.pageName="DVC LLC:Blogs:DVC News for Partners:78382-Hot topics, biotech funding, and abstract deadlines";
    s.channel=window.location.hostname;
    s.products="78382";
    s.prop1="DVC LLC";
    s.prop2="DVC LLC:Blogs";
    s.prop3="DVC LLC:Blogs:DVC News for Partners";
    s.prop8="Blogs";
    s.prop9="78382";
    s.prop10="1819";
    s.prop16="Managed Multipurpose Sites";
    s.prop19="";
    s.prop37="Zack Cannon";
    s.prop38="Awareness";
    s.eVar44 = "D=c38";
    s.prop41="TDM";
    s.eVar46 = "D=c41";
    contentID="78382";
    zoneID = "265";
    contentTypeID = "17";
    s.eVar9="D=c1";
    s.eVar10="D=c16";
    s.eVar11="Blogs";
    s.eVar12="D=pageName";
    s.eVar13="D=c19";
    s.eVar45="D=c37";
    s.eVar8="D=c9";
    
    s.prop12 = document.location.pathname + document.location.search;
    s.prop13="en-US";
    s.hier1 = document.location.hostname + ':' + s.pageName;
    createPublicPage(contentID,contentTypeID,s.prop8,zoneID,s.prop1,s.prop19);


    $csc().analytics.visitorOrg.buildPublic();
    _gaq = _gaq || [];
   setupGA(_gaq);

  </script>

  <script type="text/javascript">
  <!-- if(navigator.appVersion.indexOf('MSIE')>=0)document.write(unescape('%3C')+'\!-'+'-') //-->
  </script>
  <noscript>
  <a href="http://www.omniture.com">
    <img src="http://computersciences.112.2o7.net/b/ss/csccom/1/H.15.1--NS/0" height="1" width="1" style="border: 0;" alt="" />
  </a>
  </noscript>

  <div class='mboxDefault'></div>
  <script type='text/javascript'>
  mboxCreate('page',
'entity.id=78382',
'entity.name=Hot topics, biotech funding, and abstract deadlines',
'entity.pageURL=/dvc/blog/41185/78382-hot_topics_biotech_funding_and_abstract_deadlines',
'entity.message=The latest biopharmaceutical product development and government contracting news and...',
'entity.categoryId=265',
'entity.content_type_id=17',
'entity.thumbnailURL=',
'entity.key_content_type=0',
'entity.locale=en-US',
'entity.listing=0',
'user.categoryId=265');
  </script>

<div id="viewporter">
  <header>
    <div id="mobiTagLine">
      <p>
        A global leader in providing technology enabled business solutions and services
      </p>
    </div>
    <div class="mainLogo">
      <a href="../../../index.html">
        <img src="../../../assets/new/logo.png" alt="CSC Logo - A global leader in providing technology enabled business solutions and services." /></a>
      <span class="globalHeadline">A global leader in providing technology enabled business solutions and services.</span>
    </div>
    <div id="country">
      <div><a href="javascript:void(0);" class="countryHide countrySelector">Worldwide</a><a id="countrySelector" class="countryHide countrySelector"></a></div>
      <div id="country-select" style="display:none;">
        <!--link href="/stylesheets/user/country_select_styles-min.css" rel="stylesheet" type="text/css" /-->
<div class="unitedstates">
	<a href="../../../index.html">United States</a>
</div>
<div class="australia">
	<a href="../../../au.html">Australia</a>
</div>
<div class="austria">
	<a href="../../../de.html">Austria</a>
</div>
<div class="belgium">
	<a href="../../../be.html">Belgium</a>
</div>
<div class="brazil">
	<a href="../../../br_pt.html">Brazil</a>
</div>
<div class="bulgaria">
	<a href="../../../eastern_europe.html">Bulgaria</a>
</div>
<div class="canada">
	<a href="../../../ca_en.html">Canada</a>
</div>
<div class="canada">
	<a href="../../../ca_fr.html">Canada [fr]</a>
</div>
<div class="chile">
	<a href="../../../cl.html">Chile</a>
</div>
<div class="china">
	<a href="../../../cn_cn.html">China</a>
</div>
<div class="czech">
	<a href="../../../eastern_europe.html">Czech Republic</a>
</div>
<div class="denmark">
	<a href="../../../dk.html">Denmark</a>
</div>
<div class="france">
	<a href="../../../fr.html">France</a>
</div>
<div class="germany">
	<a href="../../../de.html">Germany</a>
</div>
<div class="hongkong">
	<a href="../../../hk_en.html">Hong Kong</a>
</div>
<div class="india">
	<a href="../../../in.html">India</a>
</div>
<div class="italy">
	<a href="../../../it.html">Italy</a>
</div>
<div class="japan">
	<a href="../../../jp_jp.html">Japan</a>
</div>
<div class="korea">
	<a href="../../../kr.html">Korea</a>
</div>
<div class="lithuania">
	<a href="../../../lt.html">Lithuania</a>
</div>
<div class="luxembourg">
	<a href="../../../lu.html">Luxembourg</a>
</div>
<div class="malaysia">
	<a href="../../../my.html">Malaysia</a>
</div>
<div class="netherlands">
	<a href="../../../nl.html">Netherlands</a>
</div>
<div class="norway">
	<a href="../../../no.html">Norway</a>
</div>
<div class="poland">
	<a href="../../../eastern_europe.html">Poland</a>
</div>
<div class="portugal">
	<a href="../../../pt.html">Portugal</a>
</div>
<div class="romania">
	<a href="../../../eastern_europe.html">Romania</a>
</div>
<div class="singapore">
	<a href="../../../sg.html">Singapore</a>
</div>
<div class="slovakia">
	<a href="../../../eastern_europe.html">Slovakia</a>
</div>
<div class="southafrica">
	<a href="../../../za.html">South Africa</a>
</div>
<div class="spain">
	<a href="../../../es.html">Spain</a>
</div>
<div class="sweden">
	<a href="../../../se.html">Sweden</a>
</div>
<div class="switzerland">
	<a href="../../../de.html">Switzerland</a>
</div>
<div class="thailand">
	<a href="../../../th_en.html">Thailand</a>
</div>
<div class="unitedkingdom">
	<a href="../../../uk.html">United Kingdom</a>
</div>
<div class="vietnam">
	<a href="../../../vn_en.html">Vietnam</a>
</div>
<div class="vietnam">
	<a href="../../../vn_vn/index.html">Vietnam [vn]</a>
</div>

      </div>
      <div id="search">
        <form action="/search" method="get" name="searchForm" id="searchForm">
          <ul>
            <li>
              <input id="searchField" type="text" name="q"  />
              <input type="hidden" value="265" name="zone_id" id="gsa_zone_id" /><input type="hidden" value="en-US" name="locale" id="gsa_locale"/>
            </li>
            <li><input id="searchSubmit" class="hidden searchBtn" type="submit" /></li>
          </ul>
        </form>
      </div>
    </div>
    <nav id="mobiMainNav">
      <ul>
        <li id="mobiCountry"><a href="javascript:void(0);">&nbsp;</a> </li>
        <li id="mobiNav"><a href="javascript:void(0);">&nbsp;</a> </li>
        <li id="mobiSearchBtn"><a href="javascript:void(0);">&nbsp;</a> </li>
      </ul>
      <div id="mobileSearch" style="display:none">
        <div class="mobileSearchWrap">
          <input type="text" name="searchText" id="mobileSearchInput" /><a id="mobiSearchImage" href="javascript:void(0);"></a>
        </div>
      </div>
      <div id="mobileNav" style="display:none">
        <ul class="mobinav" style="">
	<li class="solutionsLink">
		<a href="../../offerings/44393.html">Services</a></li> 
	</li>
	<li class="successLink">
		<a href="../../ds/16190/16326-team_with_dvc.html">Partners</a></li>
	</li>
	<li class="insightsLink">
		<a href="../../ds/11646/15182-dvc_company_information.html">About Us</a></li>
	</li>
	<li class="contactLink">
		<a href="../../ds/16321/16362-job_openings.html">Careers</a></li>
	</li>
	<li class="aboutLink">
		<a href="../../contact_us.html">Contact Us</a>
	</li>
</ul>
      </div>
    </nav>
    <div id="loginSection">
      <div id="visitor_login_section" class="loginSection unhidden"><a href="javascript:void(0);" id="nav_account_create" onclick="accountPopupWindow('account_create');">Register</a><span class="nav_account_spacer">&nbsp;|&nbsp;</span><a href="javascript:void(0);" id="nav_account_login" onclick="accountPopupWindow('account_login');"><span class="nav_account_spacer">Login</span></a></div>
<div id="visitor_welcome_section" class="loginSection hidden"><span class="nav_account_spacer">Welcome,&nbsp;</span><label id="nav_edit_profile" style="cursor:pointer;" onclick="accountPopupWindow('editprofile');"><span id="visitor_name"></span></label><span class="nav_account_spacer">&nbsp;|&nbsp;</span><a href="../../../utils/logout_visitor.html" id="nav_logout_visitor">Log&nbsp;Out</a></div>
    </div>
    <div class="wrapper">
  <nav id="globalNav">
    <ul id="nav">
      <li id="solutionsLink">
	<a href="../../offerings/44393.html">Services</a></li>
      <li id="successLink">
        <a href="../../ds/16190/16326-team_with_dvc.html">Partners</a></li>
      <li id="insightsLink">
        <a href="../../ds/11646/15182-dvc_company_information.html">About Us</a></li>
      <li id="contactLink">
        <a href="../../ds/16321/16362-job_openings.html">Careers</a></li>
      <li id="aboutLink">
        <a href="../../contact_us.html">Contact Us</a>
      </li>
    </ul>
  </nav>
</div>
  </header>
  <div class="breadcrumbs wrapper" itemprop="breadcrumb">
    <ul class='breadCrumbs'> <li><a href='../../../index.html'>Home</a> / </li> <li><a href='../../../dvc.html'>DVC LLC</a> / </li> <li><a href='../41185.html'>DVC News Updates for Partners</a> / </li> <li>Hot topics, biotech funding, and abstract deadlines</li> </ul>
  </div>
  <nav class="mobiSecondaryNav">
    <ul>
      <li id="mobiBack"><a href="../41185.html">Back</a> </li>
      <li id="mobiBackLabel">&nbsp;</li>
      <li id="mobiMoreLinks"><a href="javascript:void(0);">More Links</a> </li>
    </ul>
  </nav>
  <div id="iscrollWrapper">
    <div class="scrollwrap">
      <!-- Content Start -->

      
<section id="mainContent" class="rightSideBar">
  <div class="wrapper">
    
    <!-- Share Bar Plugin DIV Container -->
<div id="gigyaButtons"></div>
<script type="text/javascript">
  $csc().gigya.showShareBar();
</script>
<!-- End Share Bar Code -->
    <article class="pageContent" itemprop="mainContentOfPage">
    <!-- Gigya Bar -->
    <article class="blogPost">
    <section>
      <h1>Hot topics, biotech funding, and abstract deadlines</h1>
      <time>2012-02-01</time>
      <p><h2></h2>
<h2><strong>Feature: Hot Topics</strong></h2>
<p>Thanks for reading! In case you missed an issue, check out our most popular newsletter features from the last two years.</p>
<ul>
<li><a href="../../news/46817-dvc_presentation_government_contracting_and_earned_value_management_evm.html"><img style="float: right; margin: 8px;" alt="&quot;Thank you!&quot; written on an old-fashioned typewriter" src="http://assets1.csc.com/dvc/images/thankyou_typewriter.jpg" height="149" width="225" />Earned Value Management and Government Contracting</a> - Earned value management integrates scope, cost and schedule into a methodology for maintaining a budget with any project. Government agencies increasingly require a validated EVMS system for financial reporting.</li>
<li><a href="../../ds/16378/38165-%20%20special_edition_bioinformatics_and_the_future_of_medical_research_and_clinical_practice.html">Bioinformatics and the Future of Medical Research and Clinical Practice</a> - The enormous advances in biological technology over the past four decades have led to a profound change in how information is processed. In this paper, the discipline, the tools, and the potential for the future are explored.</li>
<li><a href="../../news/44109-lessons_learned_and_best_practices_in_medical_countermeasure_development.html">Lessons Learned in Medical Countermeasure Development</a> - If designing and implementing processes that are efficient, successful and adaptable is an art, conforming to these processes to rigorous U.S. Government acquisition requirements is a science.</li>
</ul>
<hr />
<h2><strong>Thoughts Wanted</strong></h2>
<p><a target="_blank" href="http://www.surveymonkey.com/s/2SV759S"><img style="float: left; margin: 5px;" alt="Man thinking, with arrows behind head on a chalkboard" src="http://assets1.csc.com/dvc/images/thinking.jpg" height="106" width="100" /></a>We're thinking about offering this newsletter every month (instead of 6 times per year), to help bring you more relevant news and events as they happen. We'd also love your feedback: what topics would you like to hear more about?</p>
<p><strong>Please</strong> <a href="http://www.surveymonkey.com/s/2SV759S"><strong>share your thoughts in this quick, two-question survey</strong></a>.</p>
<hr />
<h2></h2>
<h2><strong>TechWatch: Science News Tidbits</strong></h2>
<p><a target="_blank" href="http://www.sciencedaily.com/releases/2012/01/120112151611.htm"><img style="float: right; margin: 8px;" alt="Image of virus and blow-up of inner virus structure. In the background, cryo-electron micrographs of purified viruses with their inner structure bubbling from radiation damage. Overlaid, (left) 3D computer reconstruction of a virus's outer shell and tail in gray, with the inner structure in magenta; (right) blow-up of the inner viral structure in magenta. Image courtesy of NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases" src="http://assets1.csc.com/dvc/images/bubblegram.jpg" height="176" width="225" /></a><a href="http://www.sciencedaily.com/releases/2012/01/120112151611.htm" target="_blank">'Bubblegram' Imaging: Novel Approach to View Inner Workings of Viruses</a><br /> Researchers at the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), part of the National Institutes of Health, have developed a new way to see structures within viruses. (<em>Source: Science Daily</em>)</p>
<p><em>Image of virus and blow-up of inner virus structure. In the background, cryo-electron micrographs of purified viruses with their inner structure bubbling from radiation damage. Overlaid, (left) 3D computer reconstruction of a virus's outer shell and tail in gray, with the inner structure in magenta; (right) blow-up of the inner viral structure in magenta. Image courtesy of NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases</em></p>
<p><a href="http://online.wsj.com/article/SB10001424052970204331304577144853241744454.html?mod=wsj_share_tweet" target="_blank">A New Weapon in the Fight Against Superbugs</a><br /> “Researchers in Israel have developed a novel method of restoring antibiotic sensitivity to resistant bacteria, according to a study in the journal Applied and Environmental Microbiology. The process could eventually be used to fight hospital superbugs.” (<em>Source: The Wall Street Journal</em>)</p>
<p><a href="http://www.washingtonpost.com/national/health-science/flus-lethality-is-attributed-to-immune-systems-overreacting-to-the-virus/2011/11/21/gIQA76GpWP_story.html" target="_blank">Cytokine storm: Flu’s lethality is attributed to immune systems overreacting to the virus</a><br /> The 1918 influenza pandemic infected around a third of the world’s population and killed at least 50 million people. "Almost a century later, scientists have a better understanding of how most of those people died. They believe the culprit wasn’t influenza itself but immune system overreactions triggered by the virus.” Researchers have identified a cell—S1P1—that responds to cytokines, and they’ve figured out how to turn off that cell’s signals. The findings, <a href="http://www.cell.com/retrieve/pii/S009286741100941X" target="_blank">published in a recent issue of the journal Cell</a>, could pave the way for a new class of immune-reaction-blocking drugs that could be more effective than antiviral drugs. (<em>Source: Washington Post</em>)</p>
<p><a href="http://www.bloomberg.com/news/2011-12-05/experimental-vaccine-against-ebola-fever-protects-mice-from-deadly-virus.html" target="_blank">Experimental Vaccine Against Ebola Fever Protects Mice From Deadly Virus</a><br /> “An experimental vaccine grown in tobacco plants against deadly Ebola hemorrhagic fever protected more than 80 percent of mice given a lethal dose of the virus, and may protect humans as well, researchers said. The vaccine, unlike previous experimental vaccines, is also stable enough to stockpile in case of bioterrorism, according to the <a href="http://www.pnas.org/content/108/51/20695" target="_blank">study in the Proceedings of the National Academy of Sciences</a>. The next step is to test it in nonhuman primates.” (<em>Source: Bloomberg</em>)</p>
<hr />
<h2><strong>Industry and Government Contracting News</strong></h2>
<h3><strong>Biopharma and Biodefense</strong></h3>
<p><a target="_blank" href="http://www.foreignpolicy.com/articles/2011/12/14/the_bioterrorist_next_door"><img style="float: right; margin: 8px;" alt="Green biohazard symbol on black background, with computer imagery" src="http://assets1.csc.com/dvc/images/biohazard_computerized.jpg" height="169" width="225" /></a>Read about <a href="http://www.foreignpolicy.com/articles/2011/12/14/the_bioterrorist_next_door" target="_blank">the bioterrorist next door</a>, from Foreign Policy.</p>
<p>A <a href="http://www.scientificamerican.com/article.cfm?id=new-h3n2-flu-strain-from-swine" target="_blank">new flu strain</a> (a swine origin influenza A virus of the H3N2 subtype) is making WHO nervous, and novel flu cases prompted <a href="http://www.cidrap.umn.edu/cidrap/content/influenza/swineflu/news/dec2811guidance.html" target="_blank">new CDC guidance</a>.</p>
<p>Curious about what’s been approved? Here’s a handy chart of <a href="http://www.fda.gov/BiologicsBloodVaccines/DevelopmentApprovalProcess/BiologicalApprovalsbyYear/ucm242933.htm" target="_blank">FDA biological approvals by year</a>.</p>
<p>DHS <a href="http://www.homelandsecuritynewswire.com/dr20111202-detecting-botulinum-toxin" target="_blank">awarded a contract</a> to develop an assay capable of detecting single molecules of botulinum toxin.</p>
<p>A <a href="http://www.medindia.net/news/Researchers-Discover-New-Tick-borne-Disease-94513-1.htm" target="_blank">new tick-borne infection</a> has been discovered, with eight reported cases, and a <a href="http://news.sciencemag.org/sciencenow/2012/01/new-animal-virus-takes-northern-.html?rss=1&utm_source=twitterfeed&utm_medium=twitter" target="_blank">new animal virus</a> has taken Northern Europe by surprise.</p>
<p>Chicago has a new bio-attack response facility.</p>
<p>NIAID has begun enrollment for a <a href="http://www.niaid.nih.gov/news/newsreleases/2011/Pages/ChikungunyaVaxTrial.aspx" target="_blank">Chikungunya vaccine trial</a>.</p>
<p>In the journal mAbs: <a href="http://www.landesbioscience.com/journals/mabs/article/17621/%20/" target="_blank">Antibodies for biodefense</a>.</p>
<p>Genetic Engineering &amp; Biotechnology News outlines <a target="_blank" href="http://www.genengnews.com/gen-articles/emerging-trends-for-predictive-toxicology/3933?page=1">emerging trends in predictive toxicology</a>.</p>
<p>From Nature, on <a target="_blank" href="http://www.nature.com/news/bird-flu-and-the-future-of-biosecurity-1.9784">bird flu and the future of biosecurity</a>.</p>
<p>NIH has <a target="_blank" href="http://www.nih.gov/news/health/dec2011/od-23.htm">established</a> a National Center for Advancing Translational Sciences.</p>
<p>If you'll allow us a moment to toot our own horn, DynPort <a href="../../press_releases/77621-csc_s_dynport_vaccine_company_releases_results_for_phase_2_botulinum_vaccine_clinical_trial.html">announced results</a> of our botulinum neurotoxin vaccine Phase 2 clinical trial.</p>
<h3><strong>Government Contracting and Business</strong></h3>
<p><strong>Funding:</strong> Maryland Stem Cell Research Commission has a new program for <a target="_blank" href="http://www.mscrf.org/_media/client/pdf/2012PreclinicalandClinicalRFAPRFINAL.pdf">preclinical and research grants</a> (PDF, 26KB)<br /><br /><strong>Funding:</strong> The Maryland Biotechnology Center’s (MBC) <a target="_blank" href="http://www.marylandbiocenter.org/businessdevelopment/Pages/biotechnologydevelopmentgrants.aspx">Biotechnology Development Awards</a> provide funding up to $200K to advance biotechnology research and development in Maryland. Applications due <strong>February 15, 2012</strong>.<br /><br /><a target="_blank" href="http://www.genengnews.com/gen-articles/funding-solutions-for-life-science-startups/3956/">Funding solutions for life science startups</a>, from Genetic Engineering and Biotechnology News<br /><br />From <a target="_blank" href="http://www.slate.com/articles/technology/future_tense/2012/01/anti_vaccine_activists_9_11_deniers_and_google_s_social_search_.single.html">Slate</a>, does Google have a responsibility to help stop the spread of 9/11 denialism, anti-vaccine activism, and other fringe beliefs?<br /> <br />Washington Business Journal on <a target="_blank" href="http://www.bizjournals.com/washington/blog/fedbiz_daily/2011/12/the-changing-art-of-business-development.html?ana=e_wash_fedbiz&page=all">the changing art of business development</a> and the <a target="_blank" href="http://www.bizjournals.com/washington/blog/fedbiz_daily/2011/12/the-increasing-burden-of-risk-in.html?ana=e_wash_fedbiz&page=all">increasing burden of risk</a> in Federal contracting.<br /><br />Procurement chief says <a target="_blank" href="http://www.bizjournals.com/washington/blog/fedbiz_daily/2011/12/procurement-chief-says-dod-wont.html?ana=e_wash_fedbiz">DoD won't target contractor profits</a>.</p>
<p><strong>Op-Ed:</strong> Do FDA Social Media Rules Still Matter?</p>
<h3></h3>
<h3><strong>Reports and Resources</strong></h3>
<p><strong>Report: </strong>HHS published its 2011-2015 Global Health Strategy (PDF, 19.7MB)<br /><br /> <strong>Report:</strong> <a target="_blank" href="http://www.state.gov/r/pa/prs/ps/2011/12/178402.htm">Background Briefing</a> on Biological and Toxin Weapons Convention Review Conference (Dec. 2011), from the U.S. Department of State, where Secretary of State Hillary Clinton <a target="_blank" href="http://www.msnbc.msn.com/id/45584359/ns/technology_and_science-security/t/clinton-warns-bioweapon-threat-gene-tech/#.T75AX1L2ZBk">warned</a> of bioweapon threats from gene assembly technology<br /><br /><strong>Report:</strong> <a target="_blank" href="http://i2.cdn.turner.com/cnn/2011/images/12/20/embargoed.readyornot.report.pdf">Ready or Not</a>? Protecting the Public’s Health from Diseases, Disasters and Bioterrorism (PDF, 1.4MB), from Trust for America’s Health<br /><br /><strong>Report: </strong><a target="_blank" href="http://csis.org/files/publication/111205_Cochi_FutureGlobalImmun_Web.pdf">The Future of Global Immunization</a> (PDF, 1.2MB) from CSIS Global Health Policy Center<br /><br /> <strong>Report:</strong> Institute of Medicine - Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development <a target="_blank" href="http://www.iom.edu/Reports/2011/Strengthening-a-Workforce-for-Innovative-Regulatory-Science-in-Therapeutics-Development.aspx">workshop summary</a>, including Chimpanzees in Biomedical and Behavioral Research: <a target="_blank" href="http://www.iom.edu/Reports/2011/Chimpanzees-in-Biomedical-and-Behavioral-Research-Assessing-the-Necessity.aspx">Assessing the Necessity</a></p>
<p><a target="_blank" href="http://www.amazon.com/Long-Shot-Vaccines-National-Defense/dp/0674061586"><img style="float: right; margin: 8px;" alt="Long Shot by Kendall Hoyt, Ph.D. - book cover" src="http://assets1.csc.com/dvc/images/longshot_bookcover.jpg" height="196" width="129" /></a><strong>FDA guidance (Dec. 2011): </strong><a target="_blank" href="http://www.fda.gov/downloads/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/Guidances/Vaccines/UCM282995.pdf">General Principles for the Development of Vaccines to Protect Against Global Infectious Diseases</a> (PDF, 58KB)</p>
<p><strong>App: </strong>New for clinicians, a <a target="_blank" href="http://itunes.apple.com/us/app/clinicians-biosecurity-resource/id494187491?mt=8">biosecurity iPhone app</a><br /><br /> <strong>Database:</strong> NIH eRMa – <a target="_blank" href="http://www.ott.nih.gov/erma/">Electronic Research Materials Catalogue</a><br /><br /> <strong>Book: </strong><a target="_blank" href="http://www.amazon.com/Long-Shot-Vaccines-National-Defense/dp/0674061586">Long Shot</a>: Vaccines for National Defense, by Kendall Hoyt, Ph.D. Excerpt and interview with author in <a target="_blank" href="http://dartmed.dartmouth.edu/winter11/html/defense_mechanism/">Dartmouth Medicine</a>.<br /><br /> <strong>Featured resource:</strong> <a target="_blank" href="http://www.phe.gov/preparedness/pages/default.aspx">PHE.gov</a> from HHS Office of the Assistant Secretary for Preparedness and Response</p>
<hr />
<h2><strong>Upcoming Events</strong><strong> </strong><br /><strong> </strong></h2>
<p><strong>On demand (available now, free)</strong> - <a target="_blank" href="http://www.genengnews.com/webinars/advancing-genomics-into-personalized-medicine/150/">Advancing Genomics into Personalized Medicine</a>, from GEN<br /><br /><strong>February 8-10, 2012 and September 5-7, 2012, Bethesda, MD –</strong> <a target="_blank" href="http://www.biotrac.com/pages/Tracs/Trac31.html">Vaccines: Development and Evaluation of Efficacy</a> (a NIH <a target="_blank" href="http://www.biotrac.com/index.html">BIO-TRAC</a> workshop)<br /><br /><strong>February 10, 2012, Bethesda, MD – </strong><a target="_blank" href="http://www.techcouncilmd.com/events/events_showEvent.php?evt_id=429">MdBio Leadership Series</a> with FDA Commissioner Hamburg<br /><br /><strong>February 14-15, 2012, Dubai, United Arab Emirates –</strong> <a target="_blank" href="http://www.biotechworldcongress.com/">1st Biotechnology World Congress</a><br /><br /><strong>February 15, 2012</strong> is the deadline to <a target="_blank" href="http://www.surveymonkey.com/s/2012ViEAwards">nominate</a> a deserving partner or colleague for the 2012 World Vaccine Congress Vaccine Industry Excellence Awards.<br /><br /><strong>February 21-22, 2012, Manchester, UK </strong>– <strong> </strong><a target="_blank" href="http://www.biomarkers-congress.com/">7th Annual Biomarkers Congress</a><br /><br /><strong>February 21-23, 2012, San Francisco, CA –</strong> <a target="_blank" href="http://www.triconference.com/">Molecular Med TRI CON 2012</a> featuring diagnostics, drug discovery and development, informatics and cancer tracks <br /><br /><strong>February 26-28, 2012, Vancouver, BC – </strong>10th Annual BioPartnering North America<br /><br /><strong>February 26-29, 2012, Washington, DC </strong><strong>–</strong><strong> </strong><a target="_blank" href="http://www.asmbiodefense.org/">10th ASM Biodefense and Emerging Diseases Research Meeting</a>.  Visit DynPort in booth #38, or <a target="_blank" href="../../registrations/546.html">contact us</a> to arrange a private meeting.</p>
<p><strong><img style="float: right; margin: 8px;" alt="Independence Hall, Philadelphia, PA" src="http://assets1.csc.com/dvc/images/IndependenceHall_Philadelphia.jpg" height="170" width="225" />March 12-13, 2012, Philadelphia, PA – </strong><a target="_blank" href="http://www.healthtech.com/NGL">Encouraging Development of Therapeutics for Neglected Diseases</a><br /><strong> </strong></p>
<p><strong>March 12-13, 2012, Philadelphia, PA –</strong><a target="_blank" href="http://www.healthtech.com/ph3"> Phase III Clinical Trials</a><br /><br /><strong>March 12-14, 2012, Baltimore, MD –</strong> NDIA <a target="_blank" href="http://www.ndia.org/meetings/2300/Pages/default.aspx"> Joint CBRN Conference and Exhibition</a><br /><br /><strong>March 12-16, 2102, Hyderabad, India – </strong><a target="_blank" href="http://www.imapac.com/index.php?page=VaccineWorldSummitIndia2012">Vaccine World Summit 2012</a><br /><br /><strong>March 19-22, 2012, Baltimore, MD – </strong>Third Annual <a target="_blank" href="http://www.biotherapeuticsanalyticalsummit.com/">Biotherapeutics Analytical Summit</a>, including the inaugural <a target="_blank" href="http://www.healthtech.com/Bioassays">Bioassays for Biologics<br /></a><br /><strong>March 26-28, 2012, Rockville, MD – </strong>Mtech <a target="_blank" href="http://www.mtech.umd.edu/biotech/workshops/cell_culture_technology/index.html">Cell Culture Technology Workshop</a><br /><br /><strong>April 2-3, 2012, London, UK –</strong> <a target="_blank" href="http://www.proteins-congress.com/">5th Annual Proteins Congress</a> and <a target="_blank" href="http://www.vaccines-congress.com/">2nd Annual Vaccines Congress</a><br /><br /><strong>April 16-19, 2012, Seoul, Korea – </strong><a target="_blank" href="http://www.imapac.com/index.php?page=BiologicsWorldKorea2012">Biologics World Korea</a><br /><br /><strong>April 10-14, 2012, Washington, DC –</strong> <a target="_blank" href="http://www.terrapinn.com/conference/world-vaccine-congress-washington/index.stm">World Vaccine Congress 2012</a><br /> <br /><strong>April 17-19, 2012, San Diego, CA –</strong> <a target="_blank" href="http://www.drugdiscoverychemistry.com/">Drug Discovery Chemistry</a></p>
<p><strong>May 7-9, 2012, Baltimore, MD –</strong> NFID <a target="_blank" href="http://www.cvent.com/events/15th-annual-conference-on-vaccine-research/event-summary-217f59a0e65244738d89d9a68ad6a490.aspx">15th Annual Conference on Vaccine Research</a></p>
<p><strong>May 23-24, 2012, Brno, Czech Republic </strong><strong>–</strong> Central European Forum of Biotechnology and Innovative BioEconomy.<br /><br /><strong>June 4-7, 2012, Boston, MA – </strong><a target="_blank" href="http://www.clinicaltrialsummit.com/">Clinical Trial Oversight Summit</a> - Register by <strong>March 16, 2012</strong> to save $350. <a target="_blank" href="http://www.clinicaltrialsummit.com/ctl_content.aspx?ekfrm=110329">Submit an abstract</a>.<br /><br /><strong>June 11-12, 2012, Zurich, Switzerland </strong><strong>–</strong><strong> </strong><a target="_blank" href="http://www.drugdiscovery-summit.com/">13th Annual Drug Discovery &amp; Drug Development Leaders Summit</a> and Clinical Trials Leaders Summit<br /><br /><strong>June 18-21, 2012, Boston, MA </strong><strong>–</strong><strong> </strong><a target="_blank" href="http://convention.bio.org/">BIO 2012 Annual International Convention</a><br /><br /><strong>June 24-28, 2012, Philadelphia, PA –</strong> <a target="_blank" href="http://www.diahome.org/diahome/FlagshipMeetings/home.aspx?meetingid=27170">DIA 48th Annual Meeting</a><br /><br /><strong>August 15-16. 2012, Cambridge, MA – </strong><a target="_blank" href="http://www.healthtech.com/imt/adj">Novel Vaccines: Adjuvants &amp; Delivery Systems</a> - <a target="_blank" href="http://www.healthtech.com/SpeakerProposals.aspx?ekfrm=103976">Speaker proposals</a> due <strong>February 13, 2012</strong>.<br /><br /><strong>August 20-23, 2012, Boston, MA – </strong>CHI’s <a target="_blank" href="http://www.healthtech.com/Bioassays">4th Annual Bioprocessing Summit</a> - <a target="_blank" href="http://www.bioprocessingsummit.com/SpeakerProposals.aspx?ekfrm=104106">Speaker proposals</a> due <strong>February 20, 2012</strong>.<br /><br /><strong>August 21-22, 2012, Washington, DC – </strong>CHI's <a target="_blank" href="http://www.nextgenerationdx.com/poc">4th Annual Next Generation Dx Summit</a> - <a target="_blank" href="http://www.nextgenerationdx.com/NextGeneration_Content.aspx?ekfrm=112332">Speaker proposals</a> due <strong>February 17, 2012</strong>.<br /><br /><strong>October 10-12, 2012, Basel, Switzerland –</strong> <a target="_blank" href="http://www.amiando.com/challenges-in-malaria-research.html">Challenges in Malaria Research</a></p>
<hr />
<p><strong>Work With Us</strong></p>
<p><strong>Sponsors:</strong> DVC can help you apply your technology to new programs, or advance your product from proof-of-concept into clinical trials, and through to licensure. Learn more about our <a target="_blank" href="../../offerings/44393/51437-government_contracting_services_biopharmaceutical_product_development.html">services</a>, or <a target="_blank" href="../../registrations/546.html">contact Mike McGinnis</a> (category: Prospective Partner), New Business Director, to discuss the possibilities.</p>
<p><strong>Service Providers:</strong> We regularly post <a target="_blank" href="../../ds/31377-subcontracting_opportunities.html">new opportunities</a> to work with us on our website. DVC is currently seeking CROs to perform nonclinical reproductive toxicology studies (responses due November 4, 2011).</p>
<p><strong>Jobs</strong>: We're looking for a <a target="_blank" href="../../ds/16321/16362-job_openings.html">Therapeutic Technical Development Manager</a>.</p>
<hr />
<p><a target="_blank" href="http://twitter.com/dynport"><img alt="Follow us on Twitter" src="http://assets1.csc.com/dvc/images/twitter2.png" height="27" width="160" /></a> <a target="_blank" href="http://www.linkedin.com/company/dynport-vaccine-company-llc-a-csc-company"><img alt="Follow us on LinkedIn" src="http://assets1.csc.com/dvc/images/linkedin.png" height="27" width="158" /></a> <a target="_blank" href="../28826-bugs_and_drugs.html"><img alt="DVC Bugs and Drugs Blog" src="http://assets1.csc.com/dvc/images/Blog_Button_small.jpg" height="27" width="160" /></a></p>
<p> </p>
<p>View previous editions of this newsletter in our <a target="_blank" href="../41185-dvc_news_updates_for_partners.html">archive</a> or learn more about DVC on our <a target="_blank" href="../../../dvc.html">website</a>.</p>
<p>Like this newsletter? Plan to attend one of the events above? Have an idea for a topic we should cover? Let us know in the comments below!</p>
<p><em>DVC is not necessarily affiliated with third parties listed in this newsletter, nor does linking imply endorsement. The information herein is provided as a service for informational purposes only.</em></p>
<p>We'd love to hear from you! Feel free to comment below. Due to corporate policy, comments are moderated--we approve them during business hours Monday through Friday.</p>
<div style="position: absolute; left: -10000px; top: 0px; width: 1px; height: 1px; overflow: hidden;" id="_mcePaste">How to get more from your trade show investment</div></p>
    </section>
    </article>
		<div id="gigyaReactionsHolder"></div>


<div id="commentsPrefix"><div>COMMENTS</div></div>
<div id="gigyaSpecificityOverloader" class="gso"><div id="gigyaCommentsHolder"></div></div>


<script>
var delayedLoadComments = function () {
  //Setting up some vars used by all of the following Gigya plugins
  var defaultUserAction = new gigya.socialize.UserAction();
  defaultUserAction.setTitle(document.title);
  defaultUserAction.setLinkBack(window.location);

  var urlParts = window.location.pathname.split('/');
  var urlSlug = urlParts[urlParts.length -1].split('#')[0].split('?')[0];


  //########START REACTIONS########
  var textReactions=[
    {
      text: '',
      ID: 'thumbs_up',
      iconImgUp:'/images/new/icons/reaction_icons-thumbs_up.png',
      iconImgOver:'/images/new/icons/reaction_icons-thumbs_up.png',
      tooltip:'I give this article my thumbs up!',
      feedMessage: 'Thumbs Up!',
      headerText:'You give this article a thumbs up'
    }
    ,{
      text: '',
      ID: 'thumbs_down',
      iconImgUp:'/images/new/icons/reaction_icons-thumbs_down.png',
      iconImgOver:'/images/new/icons/reaction_icons-thumbs_down.png',
      tooltip:'I give this article my thumbs down.',
      feedMessage: 'Thumbs Down',
      headerText:'You give this article a thumbs down'
    }
  ];
  // Step 3: Define the Reactions Plugin's params object
  var reactionParams ={
    disabledProviders: 'twitter',
    barID: urlSlug, //  Identifier of the content to which this reaction refers
    containerID: 'gigyaReactionsHolder',  // Reactions Plugin DIV Container
    reactions: textReactions,  // The reaction array from Step 1
    userAction: defaultUserAction,  // The UserAction object from Step 2
    bodyText: 'Share it with your friends:', // optional - text that appears in the Share popup
    showCounts: 'top', // optional - displays the counters on top of the buttons
    cid:'',
    onReactionClicked:gigyaEventHandlers.onReactionClicked,
    onSendDone:gigyaEventHandlers.onSendDone
  };
  // Step 4: Load the Reactions Plugin:
  gigya.socialize.showReactionsBarUI(reactionParams);
  //########END REACTIONS########

  
  //########START COMMENTS########
  var commentsTemplates = {
    loginCanvas_loggedIn: '<div class="gig_photoHolder">$photoDiv</div><div class="gig_username">$username</div><div class="gig_logout"><a href="/utils/logout_visitor">Log&nbsp;Out</a></div>',
    loginCanvas_loggedOut:'<div class="gig_photoHolder"><img src="/images/new/icons/comment_default_user_icon.png" width="48" height="48" alt=""></div><div class="gig_loginmessage"><h3>Post a new comment</h3><p>You must be logged in to post comments.</p></div><div class="gig_login"><a href="javascript:void(0);" onclick="accountPopupWindow(\'account_login\');"><img src="/images/new/icons/comment_login_button.png" width="144" height="24" alt="Login"></a></div>'
  };
  //Good browsers get '100%', and Gigya's internals turn this number plus some math into 'NaNpx',
  //which is applied to the `width` value of the style attribute on EVERY ELEMENT GIGYA TOUCHES.
  //As 'NaNpx' is an invalid CSS width value, all of Gigya's width values fail, and mine take precedence.
  //IE7 & 8 try someElement.style.width = (NaN) + 'px' and error out, breaking the whole showCommentsUI invocation.
  //No responsive comments for IE7 or 8!
  var gigyaCommentsWidth = '100%';
  if($.browser.msie === true && ($.browser.version === '8.0' || $.browser.version === '7.0')){
    gigyaCommentsWidth = 640;
  }
  var showCommentsParams ={
    categoryID: "Unmoderated",
    streamID: "78382",
    useSiteLogin: true,
    onSiteLoginClicked: gigyaEventHandlers.onSiteLoginClicked,
    containerID: 'gigyaCommentsHolder',
    cid:'',
    templates: commentsTemplates,
    width:gigyaCommentsWidth,
    enabledShareProviders: 'facebook,yahoo,linkedin,pinterest',
    onSendDone: gigyaEventHandlers.onSendDone,
    onCommentSubmitted: gigyaEventHandlers.onCommentSubmitted,
    onLoad:function(){
      if(mobileDevice){
        myScroll.refresh();
      }
    }
  }
  gigya.socialize.showCommentsUI(showCommentsParams);
  //########END COMMENTS########
  
}
$csc().gigya.register(delayedLoadComments);
</script>
    </article>

  <aside class="sideBar">        
      <div>
        Welcome! Thanks for checking out news for our partners from
DynPort Vaccine Company LLC, a CSC company.<br><br>

We’ve been working in biopharmaceutical product development as a
government contractor since 1997, and have learned a few things along
the way. <strong>But... this newsletter isn't about us. </strong> <br><br>

Our goal is to share information with our partners and
potential partners, who may be interested in developments related to
government contracting and biopharmaceuticals.  (We send updates no more than once a month, so no need to worry about us overwhelming your inbox!)<br><br>

<strong>To receive these updates via email, <a href="../../ds/16190/41114-join_our_partners_e_mail_list.html"><strong>sign up here</strong></a>.</strong>  
      </div>
    </aside>
     </div>
</section>
      
<aside id="myRcmds">
  <header id="myRcmdsHeader">
    <div id="myRcmdsPersHeader"><strong>CSC Recommendations</strong></div>
    <div id="myRcmdsPersonalization">
      <div id="persIcon"><img src="../../../images/new/icons/comment_default_user_icon.png" alt=""></div>
      <div id="persButtons">
        <ul>
          <li id="myrecs_logout"><a href="../../../utils/logout_visitor.html">LOG OUT</a></li>
          <li id="myrecs_edit"><a onclick="accountPopupWindow('editprofile');" href="javascript:void(0);">EDIT PROFILE</a></li>
        </ul>
      </div>
      <div id="persProfile"><span id="myrecs_visitor_name"></span><span id="myrecs_job_title"></span></div>
    </div>
  </header>
  <div id="myRcmdsTrigger"><a id="myRcmdsChevronHolder"><span id="myRcmdsChevron">&laquo;</span></a></div>
  <section id="recs_content">
    <label>Recommended Reading</label>
    <div id="recs_div">

      <article class="contentNode">
        <a class="imgAnchor" href="../../../banking/insights/98313-changing_the_way_banks_do_business-ref=rec&dyn=0.html"><img src='../../../images/Px_Clear.gif' class='rec_insight' height="50" width="50" alt="Changing the Way Banks Do Business" /></a>
        <section class="textArea"><strong class="headline"><a href="../../../banking/insights/98313-changing_the_way_banks_do_business-ref=rec&dyn=0.html">Changing the Way Banks Do Business</a></strong><p>CSC and SAP together deliver end-to-end banking transformation with a portfolio of...</p></section>
      </article>

      <article class="contentNode">
        <a class="imgAnchor" href="../../../application_services/success_stories/78846-coca_cola_supply_chain_management_success_story-ref=rec&dyn=0.html"><img src='../../../images/Px_Clear.gif' class='rec_success' height="50" width="50" alt="Coca-Cola Supply Chain Management Success Story" /></a>
        <section class="textArea"><strong class="headline"><a href="../../../application_services/success_stories/78846-coca_cola_supply_chain_management_success_story-ref=rec&dyn=0.html">Coca-Cola Supply Chain Management Success Story</a></strong><p>Coca-Cola has dominated the beverage market for over a century, yet still values...</p></section>
      </article>

      <article class="contentNode">
        <a class="imgAnchor" href="../../../innovation/insights/92142-the_future_of_3d_printing_services_and_manufacturing-ref=rec&dyn=0.html"><img src='../../../images/Px_Clear.gif' class='rec_insight' height="50" width="50" alt="The Future of 3D Printing Services and Manufacturing" /></a>
        <section class="textArea"><strong class="headline"><a href="../../../innovation/insights/92142-the_future_of_3d_printing_services_and_manufacturing-ref=rec&dyn=0.html">The Future of 3D Printing Services and Manufacturing</a></strong><p>CSC explores the future of 3D printing and manufacturing, as 3D printing manufacturing...</p></section>
      </article>

      <article class="contentNode">
        <a class="imgAnchor" href="../../../communications_media_and_entertainment/offerings/16514/69782-csc_cloudbill-ref=rec&dyn=0.html"><img src='../../../images/Px_Clear.gif' class='rec_offer' height="50" width="50" alt="CSC CloudBill" /></a>
        <section class="textArea"><strong class="headline"><a href="../../../communications_media_and_entertainment/offerings/16514/69782-csc_cloudbill-ref=rec&dyn=0.html">CSC CloudBill</a></strong><p>An on-demand billing and subscription management Software as a Service for digital...</p></section>
      </article>

    </div>
  </section>
</aside>
<script type="text/javascript">
  var f = true;
  var myrecs_rec = 'recs_item_va';
  var myrecs_param = 'entity.id=78382';
</script>

      <!-- Content End -->
      <footer>
        <div class="wrapper">

          <section id="relationsBucket">
            <nav>
              <ul>
                <li><a class="redTri" href="../../../about_us.html"><strong>ABOUT CSC</strong></a>
                </li>
                <li><a class="blueTri" href="../../../success_stories.html"><strong>SUCCESS STORIES</strong></a>
                </li>
                <li><a class="lightBlueTri" href="../../../careersus/flxwd/16005-careers.html"><strong>CAREERS</strong></a>
                </li>
                <li><a class="purpleTri" href="../../../global_alliances.html"><strong>GLOBAL ALLIANCES</strong></a>
                </li>
                <li><a class="yellowTri" href="../../../newsroom.html"><strong>NEWSROOM</strong></a>
                </li>
                <li><a class="greenTri" href="../../../investor_relations.html"><strong>INVESTOR RELATIONS</strong></a>
                </li>
              </ul>
            </nav>
          </section>

          <section id="newsEventsBucket">
                        <strong class="headline">
              CSC WIRE</strong>
            <nav>
              <ul>
<li><a href='../../../investor_relations/press_releases/106413.html'>CSC Delivers Continued Earnings, Margin and Cash Flow Growth</a></li>
<li><a href='../../../newsroom/press_releases/105673-hcl_technologies_and_csc_announce_strategic_partnership_to_address_the_application_modernization_market.html'>HCL Technologies and CSC Announce Strategic Partnership to Address the Application Modernization Market</a></li>
<li><a href='../../../newsroom/press_releases/105677-csc_to_host_investor_call_to_discuss_strategic_partnership_with_hcl_technologies_on_wednesday_january_15_2014.html'>CSC Hosts Investor Call to Discuss Strategic Partnership with HCL Technologies</a></li>

              </ul>
            </nav>
          </section>

          <section id="contactBucket">
            <div class="thumbBucket">
  <strong class="headline">
    Engage With Us</strong>
  <!-- comment to hide this section and reveal the following section -->

 <section>
    <aside>
      <a href="../../../townhall.html" class="townHall">
	  </a>
    </aside>
    <article class="doubleLine">
      <a href="../../../townhall.html">View On-Demand <br>Town Hall Events</a>
    </article>
  </section> 

  <!-- end townhall section -->
  <!-- uncomment following content for where there is a town hall.  Be sure to specify event title and include ref=blinkgif. -->
<!-- 
    <section>
    <aside>
      <a href="/townhall/events/105269-how_will_regulatory_changes_impact_disaster_recovery?ref=blinkgif" class="townHallLive">
	  </a>
    </aside>
    <article class="doubleLine">
      <a href="/townhall/events/105269-how_will_regulatory_changes_impact_disaster_recovery?ref=blinkgif"><span class='alert'>Live Now in the Town Hall</span><br />How Will Regulatory Changes Impact Disaster Recovery?</a>
    </article>
  </section>
-->
  <!-- end live townhall section -->
  <section class="lef">
    <aside>
      <a href="../../../innovation.html" class="feedback">
        <!--img src="/images/new/icons/feedback.png" alt="Subscribe to our Newsletters" /--></a>
    </aside>
    <article>
      <a href="javascript:void(0);" onclick="premiumContentPopupWindow({id: '7829', mediaType: 'newsletter', type: ''}); ">Get our Newsletters</a><br />
     </article>
  </section>

  <section>
    <aside>
      <a href="../../../engage_communities.html" class="community">
        <!--img src="/images/new/icons/communities.png" alt="CSC Communities" /--></a>
    </aside>
    <article>
      <a href="../../../engage_communities.html"> Join our Communities</a>
    </article>
  </section>

  <section class="feedbackSection">
    <aside>
      <a href="javascript:void(0);" onclick="surveyPopupWindow('http://survey.omniture.com/d1/hosted/b22135be47','',1000,600);" id="engageWithUs" class="lef">
        <!--img src="/images/new/icons/forums.png" alt="Feedback" /--></a>
    </aside>
    <article>
      <a href="javascript:void(0);" onclick="surveyPopupWindow('http://survey.omniture.com/d1/hosted/b22135be47','',1000,600);">Give Your Feedback</a>
    </article>
  </section>
</div>
          </section>

          <section id="socialBucket">
            <strong class="headline">
              Follow Us</strong>
            <nav class="social footer">
              <!-- Follow Bar plugin DIV container -->
              <div id="gigyaFollowFooter"></div>
              <div id="gigyaFollowFooterMobile">
                <ul>
                  <li><a href="http://www.facebook.com/pages/CSC/51414306171?v=app_101332539959471" class="facebook" target="_blank">&nbsp;</a></li>
                  <li><a href="http://twitter.com/#!/CSCNews" class="twitter" target="_blank">&nbsp;</a></li>
                  <li><a href="http://www.linkedin.com/company/csc" class="linkedin" target="_blank">&nbsp;</a></li>
                  <li><a href="../../../feeds.html" class="rss" target="_blank">&nbsp;</a></li>
                  <li><a itemprop="publisher" href="https://plus.google.com/118416213869891352236" class="googleplus clearText" target="_blank">CSC</a></li>
                </ul>
              </div>
              <ul>
                <li>
                  <a href="http://www.youtube.com/user/csc" target="_blank" class="youtube clearText">&nbsp;</a>
                </li>
              </ul>
            </nav>
          </section>
          <section id="corpBucket">
            <nav class="corpInfo">
              <ul>
  <li><a href="../../../legal.html">Legal</a>&nbsp;|&nbsp; </li>
  <li><a href="../../../privacy.html">Privacy</a>&nbsp;|&nbsp; </li>
  <li><a href="../../../site_map.html">Site Map</a>&nbsp; </li>
  <li>&copy; Computer Sciences Corp </li>
</ul>

            </nav>
          </section>
        </div>
      </footer>
    </div>
  </div>
  <!-- scripts -->
  <script type="text/javascript" src="http://www.google.com/jsapi?key=ABQIAAAAmQdrOgG-5AIXvyPvLF37UxSkoY0ZZixtVMJANGkGJlQelbG63hREfyZFOAPj93RuUqgytyCufo6x5Q">
</script>

<script type="text/javascript" src="http://assets2.csc.com/javascripts/googlefeedfetcher.js">

/***********************************************
* gAjax RSS Feeds Displayer- (c) Dynamic Drive (www.dynamicdrive.com)
* This notice MUST stay intact for legal use
* Visit http://www.dynamicdrive.com/ for full source code
***********************************************/

</script>

<style type="text/css">

.labelfield{ /*CSS for label field in general*/
color:brown;
font-size: 90%;
}

.datefield{ /*CSS for date field in general*/
color:gray;
font-size: 90%;
}

#example1 li{ 
margin-bottom: 8px;
padding-bottom: 8px;
margin-left:-28px;
text-indent:0px;
}
</style>
  <!-- end of scripts -->
  
</div>
 <script src="../../../javascripts/user/twistage_omniture-min-19b876fa394902ce781dfc20f23ba899.js" type="text/javascript"></script>
 <img src="http://a.company-target.com/pixel?id=1372868710&type=js" alt="pixel" style="display:none"/>
<img src="http://a.company-target.com/pixel?id=1372868656&type=js" alt="pixel" style="display:none"/>
 <script type="text/javascript">
    var _elqQ = _elqQ || [];
    _elqQ.push(['elqSetSiteId', '3015']);
    _elqQ.push(['elqTrackPageView']);
    
    (function () {
        function async_load() {
            var s = document.createElement('script'); s.type = 'text/javascript'; s.async = true;
            s.src = '//img.en25.com/i/elqCfg.min.js';
            var x = document.getElementsByTagName('script')[0]; x.parentNode.insertBefore(s, x);
        }
        if (window.addEventListener) window.addEventListener('DOMContentLoaded', async_load, false);
        else if (window.attachEvent) window.attachEvent('onload', async_load); 
    })();
</script>
</body>
</html>
